Statistics at a Glance

At a Glance

Estimated New Cases in 2025 84,870

% of All New Cancer Cases 4.2%

Estimated Deaths in 2025 17,420

% of All Cancer Deaths 2.8%

5-Year
Relative Survival

79.0% 2015–2021
Year Rate of New Cases — SEER 8 Rate of New Cases — SEER 12 Death Rate — U.S. 5-Year Relative Survival — SEER 8
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 19.03 19.59 - - 5.50 5.53 72.22% 72.79%
1976 19.57 19.64 - - 5.59 5.53 73.01% 73.39%
1977 18.81 19.70 - - 5.53 5.53 74.23% 73.98%
1978 19.79 19.75 - - 5.45 5.42 75.86% 74.56%
1979 19.72 19.81 - - 5.25 5.30 74.12% 75.13%
1980 19.98 19.86 - - 5.18 5.19 75.03% 75.69%
1981 20.11 19.91 - - 5.08 5.08 78.57% 76.24%
1982 19.81 19.97 - - 5.00 4.98 76.37% 76.77%
1983 19.51 20.02 - - 4.89 4.87 77.48% 77.30%
1984 20.39 20.08 - - 4.75 4.77 77.66% 77.82%
1985 20.07 20.13 - - 4.67 4.67 77.31% 78.32%
1986 20.96 20.19 - - 4.54 4.57 77.94% 78.82%
1987 21.16 20.24 - - 4.42 4.48 78.60% 79.31%
1988 20.37 20.30 - - 4.43 4.47 79.40% 79.78%
1989 20.73 20.36 - - 4.50 4.46 80.85% 80.25%
1990 20.66 20.41 - - 4.51 4.45 81.17% 80.24%
1991 20.55 20.47 - - 4.43 4.45 80.39% 80.23%
1992 20.78 20.52 20.32 19.99 4.47 4.44 80.06% 80.22%
1993 20.84 20.58 20.31 20.01 4.48 4.43 80.33% 80.20%
1994 20.07 20.64 19.62 20.02 4.48 4.42 80.72% 80.19%
1995 20.09 20.69 19.70 20.03 4.36 4.42 81.75% 80.18%
1996 20.40 20.75 19.78 20.05 4.43 4.41 79.93% 80.17%
1997 20.72 20.81 20.11 20.06 4.40 4.40 78.99% 80.16%
1998 20.96 20.86 20.03 20.07 4.39 4.39 79.09% 80.14%
1999 21.25 20.92 20.17 20.08 4.37 4.39 77.76% 80.13%
2000 21.00 20.98 20.01 20.10 4.33 4.38 80.50% 80.12%
2001 21.28 21.04 20.27 20.11 4.35 4.38 81.59% 80.11%
2002 20.71 21.09 19.81 20.12 4.43 4.39 80.38% 80.09%
2003 21.22 21.15 20.56 20.13 4.31 4.39 80.87% 80.08%
2004 21.31 21.21 20.72 20.15 4.43 4.40 80.68% 80.07%
2005 21.19 21.27 20.14 20.16 4.43 4.40 80.28% 80.06%
2006 20.88 21.33 19.89 20.17 4.42 4.41 81.17% 80.05%
2007 21.22 21.13 20.26 20.19 4.45 4.41 79.18% 80.03%
2008 20.92 20.94 19.75 19.95 4.42 4.42 78.03% 80.02%
2009 20.39 20.75 19.32 19.72 4.38 4.42 79.11% 80.01%
2010 20.82 20.57 19.84 19.50 4.45 4.43 78.30% 80.00%
2011 20.05 20.38 19.01 19.27 4.45 4.43 79.27% 79.99%
2012 20.26 20.19 19.07 19.05 4.43 4.44 78.41% 79.97%
2013 19.74 20.01 18.56 18.83 4.49 4.44 79.44% 79.96%
2014 20.07 19.83 18.58 18.61 4.42 4.45 79.84% 79.95%
2015 20.06 19.65 18.59 18.40 4.46 4.45 81.75% 79.94%
2016 19.65 19.47 18.46 18.19 4.48 4.46 80.18% 79.92%
2017 19.48 19.30 18.12 17.98 4.39 4.39 82.13% 79.91%
2018 18.98 19.12 17.62 17.77 4.29 4.33 - 79.90%
2019 19.20 18.95 17.87 17.56 4.25 4.27 - 79.89%
2020 17.70 18.78 16.60 17.36 4.15 4.21 - 79.88%
2021 19.00 18.61 17.45 17.16 4.13 4.15 - 79.86%
2022 17.62 18.44 16.39 16.96 4.16 4.09 - 79.85%
2023 - - - - 4.03 4.03 - 79.84%

New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data

New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.


Rate of New Cases and Deaths per 100,000: The rate of new cases of bladder cancer was 18.0 per 100,000 men and women per year. The death rate was 4.1 per 100,000 men and women per year. These rates are age-adjusted and based on 2018–2022 cases and 2019–2023 deaths.

Lifetime Risk of Developing Cancer: Approximately 2.1 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.

Prevalence of This Cancer: In 2022, there were an estimated 744,039 people living with bladder cancer in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Bladder Cancer?

Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

79.0%

5-Year
Relative Survival

79.0%

Based on data from SEER 21 (Excluding IL) 2015–2021. Gray figures represent those who have died from bladder cancer. Green figures represent those who have survived 5 years or more.

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier bladder cancer is caught, the better chance a person has of surviving five years after being diagnosed. For bladder cancer, 33.9% are diagnosed at the local stage. The 5-year relative survival for localized bladder cancer is 72.6%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Bladder Cancer
Stage Percent of Cases 5-Year Relative Survival
In Situ
Only in Originating Layer of Cells
50% 97.9%
Localized
Confined to Primary Site
34% 72.6%
Regional
Spread to Regional Lymph Nodes
7% 40.5%
Distant
Cancer Has Metastasized
6% 9.1%
Unknown
Unstaged
3% 51.5%

SEER 21 (Excluding IL) 2015–2021, All Races, Both Sexes by SEER Combined Summary Stage

New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, bladder cancer is fairly common.

Rank Common Types of Cancer Estimated New
Cases 2025
Estimated
Deaths 2025
1. Breast Cancer (Female) 316,950 42,170
2. Prostate Cancer 313,780 35,770
3. Lung and Bronchus Cancer 226,650 124,730
4. Colorectal Cancer 154,270 52,900
5. Melanoma of the Skin 104,960 8,430
6. Bladder Cancer 84,870 17,420
7. Kidney and Renal Pelvis Cancer 80,980 14,510
8. Non-Hodgkin Lymphoma 80,350 19,390
9. Uterine Cancer 69,120 13,860
10. Pancreatic Cancer 67,440 51,980

Bladder cancer represents 4.2% of all new cancer cases in the U.S.

4.2%

In 2025, it is estimated that there will be 84,870 new cases of bladder cancer and an estimated 17,420 people will die of this disease.

Who Gets This Cancer?

Bladder cancer becomes more common with age and is more common in men than women. The rate of new cases of bladder cancer was 18.0 per 100,000 men and women per year based on 2018–2022 cases, age-adjusted.

Rate of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Bladder Cancer
Males
All Races 31.2
Hispanic 17.0
Non-Hispanic American Indian/Alaska Native 19.2
Non-Hispanic Asian/Pacific Islander 15.0
Non-Hispanic Black 19.2
Non-Hispanic White 37.5
Females
All Races 7.7
Hispanic 4.8
Non-Hispanic American Indian/Alaska Native 5.3
Non-Hispanic Asian/Pacific Islander 3.6
Non-Hispanic Black 6.0
Non-Hispanic White 9.2

SEER 21 2018–2022, Age-Adjusted

Percent of New Cases by Age Group: Bladder Cancer
Age Range Percent of New Cases
<20 0.1%
20–34 0.4%
35–44 1.2%
45–54 4.6%
55–64 16.9%
65–74 32.4%
75–84 30.2%
>84 14.1%

Bladder cancer is most frequently diagnosed among people aged 65–74.

Median Age
At Diagnosis

73

SEER 21 2018–2022, All Races, Both Sexes

Who Dies From This Cancer?

Bladder cancer is the tenth leading cause of cancer death in the United States. The death rate was 4.1 per 100,000 men and women per year based on 2019–2023 deaths, age-adjusted.

Death Rate per 100,000 Persons by Race/Ethnicity & Sex: Bladder Cancer
Males
All Races 7.1
Hispanic 3.7
Non-Hispanic American Indian/Alaska Native 3.8
Non-Hispanic Asian/Pacific Islander 2.8
Non-Hispanic Black 5.2
Non-Hispanic White 8.0
Females
All Races 2.0
Hispanic 1.2
Non-Hispanic American Indian/Alaska Native 1.8
Non-Hispanic Asian/Pacific Islander 0.9
Non-Hispanic Black 2.1
Non-Hispanic White 2.2

U.S. 2019–2023, Age-Adjusted

Percent of Deaths by Age Group: Bladder Cancer
Age Range Percent of Deaths
<20 0.0%
20–34 0.1%
35–44 0.4%
45–54 2.0%
55–64 9.9%
65–74 22.8%
75–84 32.9%
>84 31.9%

The percent of bladder cancer deaths is highest among people aged 75–84.

Median Age
At Death

79

U.S. 2019–2023, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, age-adjusted rates for new bladder cancer cases have been falling on average 0.9% each year over 2013–2022. Age-adjusted death rates have been falling on average 1.1% each year over 2014–2023. 5-year relative survival trends are shown below.

Interactive Statistics with SEER*Explorer

With SEER*Explorer, you can...
  • Create custom graphs and tables
  • Download data and images
  • Share links to results

SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.

Explore Additional Bladder Cancer Statistics

More About This Cancer

Cancer and the Bladder

Figure: Anatomy of the male urinary system (left)
and female urinary system (right)

Figure: Anatomy of the male urinary system (left) and female urinary system (right) showing the kidneys, ureters, bladder, and urethra.

The bladder is a hollow organ in the lower part of the abdomen. It is shaped like a small balloon and has a muscular wall that allows it to get larger or smaller. The urine passes from the two kidneys into the bladder through two tubes called ureters. The bladder is emptied through another tube called the urethra.

There are three types of bladder cancer that begin in cells in the lining of the bladder: transitional cell carcinoma; squamous cell carcinoma; and adenocarcinoma.

Cancer that is confined to the lining of the bladder is called superficial bladder cancer. Cancer that begins in the transitional cells may spread through the lining of the bladder and invade the muscle wall of the bladder or spread to nearby organs and lymph nodes; this is called invasive bladder cancer.

Additional Information

More Information

Here are some resources for learning more about bladder cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Bladder Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/urinb.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.

Estimates of new cases and deaths for 2025 are projections made by the American Cancer Society (ACS), based on earlier reported data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.